RELIAGENE TECHNOLOGIES

ReliaGene Technologies

#More

RELIAGENE TECHNOLOGIES

Industry:
Information Technology

Status:
Active


More informations about "ReliaGene Technologies"

Reliagene Technologies - PitchBook

Provider of DNA testing services in courts. The company provides polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), mitochondrial DNA sequencing โ€ฆSee details»

ReliaGene Technologies Inc - Company Profile and News

Company profile page for ReliaGene Technologies Inc including stock price, company news, executives, board members, and contact informationSee details»

ReliaGene Technologies - LinkedIn

Formerly DynaLIFE (Visit: Alberta Precision Labs) Hospitals and Health Care Edmonton, ABSee details»

ReliaGene Technologies - Crunchbase Company Profile & Funding

Who are ReliaGene Technologies's competitors? Alternatives and possible competitors to ReliaGene Technologies may include Starling Partners, BitMagic Technologies, and โ€ฆSee details»

ReliaGene Technologies, Inc. - Drug pipelines, Patents, Clinical โ€ฆ

Explore ReliaGene Technologies, Inc. with its drug pipeline, therapeutic area, technology platform, 11 literature.See details»

Press Release - SEC.gov

ReliaGene is a prominent and well respected provider of forensic and paternity DNA analysis services based in New Orleans, Louisiana and had 2006 annual revenue of $7.5 million. โ€œThe โ€ฆSee details»

ReliaGene Technologies, Inc. - VentureRadar

ReliaGene Technologies, Inc. VentureRadar profile. Find out more about ReliaGene Technologies, Inc. including the VentureRadar Innovation and Growth scores, Similar โ€ฆSee details»

ReliaGene Technologies - Drug pipelines, Patents, Clinical trials

Explore ReliaGene Technologies with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»

ReliaGene Technologies - Crunchbase

ReliaGene TechnologiesSee details»

Orchid Cellmark to buy ReliaGene for $8.6 mln | Reuters

Oct 22 (Reuters) - Orchid Cellmark Inc said it agreed to acquire ReliaGene Technologies Inc for $5.6 million in cash and $3 million in shares of Orchid's restricted common stock. The deal will...See details»

Sudhir Sinha, Ph.D. | Tulane School of Medicine - Tulane University

In 1990, prior to establishing InnoGenomics, Dr. Sinha was a founder, majority owner and laboratory director at ReliaGene Technologies, an accredited DNA testing facility located in the โ€ฆSee details»

Sudhir Sinha - Chief Science Officer, Board, Co-founder at Cadex ...

As President and Chief Scientist at ReliaGene, one of Dr. Sinhaโ€™s major achievements was designing and producing the first commercial Y-STR DNA testing kit.See details»

Audit Report - United States Department of Justice Office of the ...

ReliaGene Technologies, Inc., is an independent, privately-held corporation specializing in convicted offender databasing, forensic casework analysis, paternity testing, molecular โ€ฆSee details»

Orchid Cellmark to Buy ReliaGene Technologies, Inc. for $8.6

Oct 23, 2007ย ยท PRINCETON, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, today announced that it has โ€ฆSee details»

| BioWorld

Nov 20, 2003ย ยท NEW ORLEANS - It's been well over a decade since ReliaGene Technologies Inc. opened the doors on its DNA analysis business, but the company quickly established a โ€ฆSee details»

ReliaGene Technologies Careers and Employment | Indeed.com

Find out what works well at ReliaGene Technologies from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular โ€ฆSee details»

Forensic validation studies on the Y-Plexโ„ข 6 Kit - ScienceDirect

Jan 1, 2003ย ยท The Y-PLEXโ„ข 6 Kit (Reliagene Technologies) is a commercial multiplex PCR system for the simultaneous analysis of six tetranucleotide STR loci (DYS393, DYS19, โ€ฆSee details»

ReliaGene Technologies - Drug pipelines, Patents, Clinical trials

Explore ReliaGene Technologies with its drug pipeline, therapeutic area, technology platform, .See details»

PRESS RELEASE: Orchid Cellmark to Buy ReliaGene for $8.6 Million

Oct 23, 2007ย ยท PRINCETON, N.J., Oct. 2w -- Orchid Cellmark, , a leading worldwide provider of identity DNA testing services, today announced that it has signed a definitive purchase โ€ฆSee details»

Development and validation of a multiplexed Y-chromosome STR โ€ฆ

Details of the development of the kit, generation and description of the allelic ladders, and validation of the multiplex PCR are presented. In addition, Y-STR allele and haplotype โ€ฆSee details»